The most common ADHD medication is amphetamine/dextroamphetamine, sold under brand names like Adderall. It accounts for roughly 49% of all stimulant prescriptions for ADHD in the United States. Methylphenidate (Ritalin, Concerta) comes in second at 22%, followed by lisdexamfetamine (Vyvanse) at 19%.
The Three Most Prescribed ADHD Medications
Nearly all ADHD prescriptions fall into one of three medications, and all three are stimulants. According to DEA prescription data from 2023, amphetamine/dextroamphetamine dominates the market with almost half of all stimulant prescriptions. Methylphenidate holds about a fifth of the market, and lisdexamfetamine takes a similar share. Together, these three account for 90% of stimulant ADHD prescriptions in the country.
Despite the name “stimulant,” these medications don’t make people with ADHD feel wired. They work by boosting two brain chemicals, dopamine and norepinephrine, that play central roles in attention, motivation, and impulse control. In a brain where those chemicals are underactive, stimulants bring them closer to typical levels, which is why they help with focus rather than creating hyperactivity.
How Stimulants Differ From Each Other
Amphetamine/dextroamphetamine and methylphenidate target the same brain chemicals but do so in slightly different ways. Some people respond well to one and poorly to the other, which is why providers sometimes switch between them during the early months of treatment. There’s no reliable way to predict which will work best for a given person before trying it.
Lisdexamfetamine is chemically related to amphetamine but designed as a “prodrug,” meaning your body has to convert it into its active form after you swallow it. This built-in delay produces a smoother onset and makes it harder to misuse, which is one reason it has become increasingly popular.
Most patients today take extended-release formulations. Physicians prescribe extended-release versions as the sole treatment for about 65% of their ADHD patients. These once-daily pills release medication gradually over 8 to 12 hours, eliminating the need to take a dose at school or work. Immediate-release versions still exist and are sometimes added in the afternoon for people who need coverage later in the day.
Non-Stimulant Alternatives
The FDA has approved four non-stimulant medications for ADHD: atomoxetine (Strattera), guanfacine (Intuniv), clonidine (Kapvay), and viloxazine (Qelbree). These work primarily by increasing norepinephrine in the brain, without the dopamine boost that stimulants provide. They tend to be less potent for core attention symptoms but carry no risk of the appetite suppression or sleep disruption that stimulants sometimes cause.
Non-stimulants are typically considered when stimulants cause intolerable side effects, when a person has a history of substance misuse, or when anxiety is a prominent part of the picture. They also take longer to reach full effect, often two to six weeks, compared to stimulants that work within an hour of the first dose.
What Guidelines Recommend by Age
Treatment recommendations shift depending on how old the patient is. For children ages 4 to 6, the American Academy of Pediatrics recommends starting with behavioral therapy, specifically parent training in behavior management and classroom interventions. Methylphenidate is the only stimulant recommended at this age, and only if behavioral approaches haven’t produced meaningful improvement.
For children 6 and older and for adolescents, the guidelines recommend FDA-approved medication combined with behavioral strategies. At this stage, providers can choose from the full range of stimulant and non-stimulant options. The combination of medication and behavioral support tends to produce better outcomes than either one alone.
Adults follow a similar medication-first approach, though behavioral therapy for adults often takes the form of cognitive behavioral therapy or coaching rather than the parent-focused training used with children. The average adult dose of methylphenidate, for reference, falls between 20 and 30 milligrams per day, split across two or three doses for immediate-release forms. Extended-release versions simplify this to a single morning dose.
What to Expect When Starting Treatment
Stimulant medications typically produce noticeable effects on the first day. You may find it easier to start tasks, follow conversations, or resist distractions. The most common side effects are reduced appetite, trouble falling asleep, and a slight increase in heart rate. These often lessen over the first few weeks as your body adjusts.
Finding the right medication and dose is usually a process of trial and adjustment. Most providers start at a low dose and increase gradually over several weeks, checking in on both symptom improvement and side effects at each step. It’s not unusual to try two or three medications before landing on the best fit. If a stimulant works but causes problematic side effects at higher doses, a provider might add a non-stimulant rather than continuing to increase the stimulant alone.
Weight loss from appetite suppression is worth monitoring, especially in children. Taking medication with or after breakfast, rather than before, and planning a larger evening meal after the medication wears off are common strategies to maintain adequate nutrition. Sleep difficulties are often managed by timing the last dose earlier in the day or switching to a formulation that wears off sooner.